These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17290394)

  • 41. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.
    Zheng YL; Loffredo CA; Yu Z; Jones RT; Krasna MJ; Alberg AJ; Yung R; Perlmutter D; Enewold L; Harris CC; Shields PG
    Carcinogenesis; 2003 Feb; 24(2):269-74. PubMed ID: 12584177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk.
    Wu X; Zheng YL; Hsu TC
    Methods Mol Biol; 2014; 1105():183-92. PubMed ID: 24623229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cigarette smoking in a multiethnic population of youth: methods and baseline findings.
    Gritz ER; Prokhorov AV; Hudmon KS; Chamberlain RM; Taylor WC; DiClemente CC; Johnston DA; Hu S; Jones LA; Jones MM; Rosenblum CK; Ayars CL; Amos CI
    Prev Med; 1998; 27(3):365-84. PubMed ID: 9612827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
    Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
    Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
    Hu W; Feng Z; Tang MS
    Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smoking-associated DNA methylation markers predict lung cancer incidence.
    Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
    Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk.
    Wu X; Roth JA; Zhao H; Luo S; Zheng YL; Chiang S; Spitz MR
    Cancer Res; 2005 Jan; 65(1):349-57. PubMed ID: 15665313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced DNA repair capacity in lung cancer patients.
    Wei Q; Cheng L; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans.
    Wrensch MR; Miike R; Sison JD; Kelsey KT; Liu M; McMillan A; Quesenberry C; Wiencke JK
    Int J Cancer; 2005 Jan; 113(1):141-7. PubMed ID: 15386428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan.
    Schwartz AG; Swanson GM
    Cancer; 1997 Jan; 79(1):45-52. PubMed ID: 8988725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
    Wang AY; Wong MS; Humbyrd CJ
    Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
    Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic instability of specific chromosomes associated with a family history of cancer.
    Zhu Y; Spitz MR; Hsu TC; Wu X
    Cancer Genet Cytogenet; 2002 Jul; 136(1):73-7. PubMed ID: 12165456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagen sensitivity has high heritability: evidence from a twin study.
    Wu X; Spitz MR; Amos CI; Lin J; Shao L; Gu J; de Andrade M; Benowitz NL; Shields PG; Swan GE
    Cancer Res; 2006 Jun; 66(12):5993-6. PubMed ID: 16778168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary mutagen exposure and risk of pancreatic cancer.
    Li D; Day RS; Bondy ML; Sinha R; Nguyen NT; Evans DB; Abbruzzese JL; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):655-61. PubMed ID: 17416754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagen sensitivity as a susceptibility marker for endometriosis.
    Lin J; Zhang X; Chen Y
    Hum Reprod; 2003 Oct; 18(10):2052-7. PubMed ID: 14507820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA repair and mutagen sensitivity in patients with triple primary cancers.
    Miller DG; Tiwari R; Pathak S; Hopwood VL; Gilbert F; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):321-7. PubMed ID: 9568788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity.
    Schantz SP; Zhang ZF; Spitz MS; Sun M; Hsu TC
    Laryngoscope; 1997 Jun; 107(6):765-81. PubMed ID: 9185733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromosome instability and risk of squamous cell carcinomas of head and neck.
    Wang LE; Xiong P; Zhao H; Spitz MR; Sturgis EM; Wei Q
    Cancer Res; 2008 Jun; 68(11):4479-85. PubMed ID: 18519711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.